SI-BONE Inc
Helen Loh has served as a member of the board of directors since April 2021. She has over 25 years of experience in brand and growth marketing at both Fortune 500 and early-stage technology companies. Currently, Ms. Loh is the Managing Director of Digital, Education and Client Marketing at Charles Schwab, where she has held roles of increasing responsibilities since 2004. Previously, Ms. Loh led Marketing and Product at several start-ups in consumer technology and enterprise software. Ms. Loh began her marketing career in brand management at The Clorox Company. Since November 2014, Ms. Loh has served on the board of directors of the Charles Schwab Foundation. Ms. Loh received a B.S. in Industrial Engineering from Stanford University and a M.B.A. from Stanford Business School
This person is not in the org chart
This person is not in any teams
This person is not in any offices
SI-BONE Inc
2 followers
SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.